Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00861575 · ClinicalTrials.gov registry record
Cardiogenomics Registry
A clinical trial of Cardiovascular Disease, sponsored by Piedmont Healthcare.
- Completed
- Registry status
- 2,601
- Enrollment target
- 1
- Study location
NCT00861575: Completed study of Cardiovascular Disease, sponsored by Piedmont Healthcare.
NCT00861575 is a study of Cardiovascular Disease that has completed, run by Piedmont Healthcare. The registered enrollment target is 2,601 participants, roughly in line with the 2,678-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00861575, a study of Cardiovascular Disease, has completed, sponsored by Piedmont Healthcare.
- COMPLETED
- Registry status
- 2,601 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.
Conditions Studied
Study Locations (1)
Georgia
- Piedmont Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,601 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-02 |
What the finished NCT00861575 record still lists
NCT00861575 is an observational study that tracks outcomes without assigning an intervention. Its 2,601 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,678-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target.
The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00861575 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT00861575 about?
NCT00861575 is a clinical study titled "Cardiogenomics Registry". This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this stu...
What is the current status of trial NCT00861575?
This trial is currently completed. The enrollment target is 2,601 participants. The study started on 2006-02. Estimated completion is 2012-02.
What conditions does trial NCT00861575 study?
This clinical trial studies the following conditions: Cardiovascular Disease.
Who is sponsoring clinical trial NCT00861575?
This trial is sponsored by Piedmont Healthcare, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00861575 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00861575's enrollment target sits among peer trials
2,601 24th of 137 higher than 114 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
WISE CVD - Continuation (WISE HFpEF)
RECRUITING
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RECRUITING · Phase 3
-
Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)
RECRUITING
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- NCT06574672 · 2,600 participants · NA
Embedded Palliative Care in the MICU
- NCT06370520 · 2,592 participants
Screening Emotions in Adolescents at the Hospital for mTBI
- NCT06018285 · 2,572 participants · NA
Stepped Approach to Reducing Risk of Suicide in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia